Clinical Trial Update: A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update: RO5093151 for non-alcoholic fatty liver disease (NAFLD) conducted by Hoffmann-La Roche has completed. The entry provides trial ov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• RO5093151

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD | Phase 1 | Status: COMPLETED